Max Healthcare Institute Limited has scheduled a meeting of the Board of Directors for Thursday, August 13, 2026. The primary agenda of the meeting is to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026 (Q1 FY2027).
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company confirms the continuation of the trading window closure for all designated persons and their immediate relatives, which was previously intimated on June 26, 2026. The trading window will remain closed until 48 hours after the declaration of the financial results.
This disclosure has been hosted on the company's website at www.maxhealthcare.in.